foxo4 dri senolytic peptide mechanism Class II senolytics inhibit survival pathways elicited by senescent FOXO4-DRI improves spermatogenesis in aged
FOXO4 DRI improves spermatogenesis in aged mice through reducing senescence associated secretory phenotype secretion from Leydig cells ScienceDirect Senolytics: from pharmacological inhibitors to immunotherapies, a promising future for patients' treatment npj Aging Development of a novel senolytic by precise disruption of FOXO4 p53 complex eBioMedicine The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications
Pay in 4 interest-free payments of $6.94 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13



